Abstract | BACKGROUND: METHODS: Twenty patients with BCCs of the head, neck, and upper extremities were enrolled in this prospective trial. Methyl aminolevulinate (MAL) (Metvixia, Galderma Laboratories, LP, Fort Worth, TX) was applied overnight (mean of 13.3 hours) before fluorescence measurements of tumor size using a clinical Wood lamp examination. RESULTS: A total of 5 (25.0%) superficial and 15 (75.0%) nodular BCCs were included in this trial. The mean tumor sizes were 263.0 mm(2) (post- Mohs micrographic surgery [MMS] defect), 239.1 mm(2) (fluorescent examination of MAL under Wood lamp), and 65.8 mm(2) (clinical size). Using interclass correlation coefficients, a high degree of consistency and absolute agreement between post-MMS defect size and fluorescent examination size was identified (interclass correlation coefficient .962). This correlation was significantly higher than that between post-MMS defect size and clinical examination (.703) and that between fluorescent and clinical examination (.651). LIMITATIONS: Although this study demonstrates the clinical feasibility of using MAL in conjunction with a Wood lamp examination to delineate tumor margins before MMS for superficial and nodular BCCs, future large-scale studies are needed. CONCLUSIONS: The use of topical MAL as a photosensitizer in conjunction with a Wood lamp examination is a simple and inexpensive investigation that can be used before MMS to delineate the margins of ill-defined tumors.
|
Authors | Emily Tierney, Jeffrey Petersen, C William Hanke |
Journal | Journal of the American Academy of Dermatology
(J Am Acad Dermatol)
Vol. 64
Issue 5
Pg. 911-8
(May 2011)
ISSN: 1097-6787 [Electronic] United States |
PMID | 21496702
(Publication Type: Journal Article)
|
Copyright | Copyright © 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved. |
Chemical References |
- Photosensitizing Agents
- methyl 5-aminolevulinate
- Aminolevulinic Acid
|
Topics |
- Aged
- Aged, 80 and over
- Aminolevulinic Acid
(analogs & derivatives)
- Carcinoma, Basal Cell
(pathology)
- Carcinoma, Squamous Cell
(pathology, surgery)
- Female
- Humans
- Male
- Middle Aged
- Mohs Surgery
- Photosensitizing Agents
- Prospective Studies
- Skin Neoplasms
(pathology, surgery)
- Spectrometry, Fluorescence
|